Please login to the form below

Not currently logged in
Email:
Password:

patient advocates

This page shows the latest patient advocates news and features for those working in and with pharma, biotech and healthcare.

CGRP migraine drugs need prior approval for use, recommends ICER

CGRP migraine drugs need prior approval for use, recommends ICER

At that meeting, panel members drawn from patient advocates, physicians, public and private payers, and drug manufacturers voted that evidence was adequate to demonstrate a net health benefit of the CGRP

Latest news

  • Shire teams up with Microsoft and EURORDIS for rare disease project Shire teams up with Microsoft and EURORDIS for rare disease project

    Will work to accelerate the time to diagnosis for children. Shire has formed a strategic alliance with Microsoft and the European rare diseases patient group organisation EURORDIS to accelerate the time ... In turn they will bring together a dedicated

  • Facing the new wave of biosimilars Facing the new wave of biosimilars

    GAfPA campaigns across Europe to ensure patient access to appropriate clinically approved therapies. ... GAfPA has and continues to work with the European Federation of Crohn’s and Colitis Associations to increase patient awareness about these

  • Snapchat arrives at scientific meetings Snapchat arrives at scientific meetings

    patient advocates of all ages.”.

  • NOR-SWITCH - the final piece in the biosimilar puzzle? NOR-SWITCH - the final piece in the biosimilar puzzle?

    But the Global Alliance for Patient Access (GAfPA) - a network of physicians and patient advocates that campaigns for patient access to appropriate clinical care and approved therapies - believes it is important ... notably in Barcelona in February 2016

  • Orphan drugs: Leading the way in patient-centricity Orphan drugs: Leading the way in patient-centricity

    Orphan drug companies collaborate with patient advocates for example to demonstrate the burden of the disease, add it to the policy agenda and help to incorporate the rare patients' benefit-risk ... Lessons in patient-centricity . Patient engagement is

More from news
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest Intelligence

  • Reaching the new influencers Reaching the new influencers

    We’re already living in a new world, and reaching its new influencers - whether these are payers, population health specialists or patient advocates - requires that leaders be fully engaged with it. ... It demands fluency not just with the science

  • Beyond caring: learning from the unsung advocates in cancer care

    What can we do for advocates? Increasing patient access to advocates has the potential to fundamentally change the cancer experience for patients and their families. ... However it’s obvious that the patient experience doesn’t stop here. Advocates

  • Optimising market research data in rare diseases Optimising market research data in rare diseases

    They are not simply a proxy for the patient who is too young or too ill; they are also information seekers, advocates and influencers on the disease course and treatment journey, ... can often reflect patient populations that are either similar or even

  • Change drivers: multi-stakeholder education and collaboration Change drivers: multi-stakeholder education and collaboration

    Challenge 2: industry silos and compliance. Over the years, a number of patient advocates and experts that I have worked with on behalf of clients have expressed frustration at the siloed ... patient advocates and clinical experts.

More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • The Heart of the Matter 6 – to tweet or not to tweet?

    Patient groups and advocates are now powerful online thought leaders in specific disease areas – and are deeply knowledgeable about the science.”. ... Its engagement with patient advocates has understandably been more conservative. But itʼs time for

  • Clark Health Communications unveils new positioning

    It also expresses feedback that CHC instinctively knows how to build successful collaborations with healthcare professionals, patient advocates, media and other stakeholders as a fundamental part of their approach to communications.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics